Literature DB >> 9140046

Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

M Kömhoff1, H J Grone, T Klein, H W Seyberth, R M Nüsing.   

Abstract

To gain insight into the roles of cyclooxygenase (COX)-1 and -2 in human kidney, we analyzed their expressions and localization in adult and fetal normal kidney. Immunohistology showed expression of COX-1 in collecting duct cells, interstitial cells, endothelial cells, and smooth muscle cells of pre- and postglomerular vessels. Expression of COX-2 immunoreactive protein could be localized to endothelial and smooth muscle cells of arteries and veins and intraglomerularly in podocytes. In contrast to the rat, COX isoforms were not detected in the macula densa. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Glomerular staining of COX-2 was detectable in podocytes only at the endstage of renal development. In summary, the localization of COX-2 suggests that this enzyme may be primarily involved in the regulation of renal perfusion and glomerular hemodynamics. The expression of COX-1 in podocytes of the fetal kidney and its absence in adult glomeruli suggests that this isoform might be involved in glomerulogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140046     DOI: 10.1152/ajprenal.1997.272.4.F460

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  62 in total

1.  Prostaglandin E(2) is crucial in the response of podocytes to fluid flow shear stress.

Authors:  Tarak Srivastava; Ellen T McCarthy; Ram Sharma; Patricia A Cudmore; Mukut Sharma; Mark L Johnson; Lynda F Bonewald
Journal:  J Cell Commun Signal       Date:  2010-04-08       Impact factor: 5.782

Review 2.  The determination and application of fixed-dose analgesic combinations for treating multimodal pain.

Authors:  Robert B Raffa; Joseph V Pergolizzi; Ronald J Tallarida
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

3.  Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats.

Authors:  A Turull; C Piera; J Queralt
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

4.  Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.

Authors:  Huifang Cheng; Xiaofeng Fan; Gilbert W Moeckel; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2011-07       Impact factor: 10.121

Review 5.  The role of the kidney in regulating arterial blood pressure.

Authors:  Hani M Wadei; Stephen C Textor
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

Review 6.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.

Authors:  M N Muscará; N Vergnolle; F Lovren; C R Triggle; S N Elliott; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 8.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 9.  Does cyclooxygenase-2 affect blood pressure?

Authors:  Hui-Fang Cheng; Raymond C Harris
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 10.  Cyclooxygenase-2 inhibitors: is there an association with coronary or renal events?

Authors:  Richard J Bing
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.